Cancer Medicine

Cancer Medicine

癌症医学

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Cancer Medicine》是由John Wiley and Sons Ltd出版社于2012年创办的英文国际期刊(ISSN: 2045-7634,E-ISSN: 2045-7634),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为ONCOLOGY。作为SCI、SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA开放获取模式(OA占比1%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比84.96%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在924篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancer Medicine审稿周期约为19 Weeks。该刊近年未被列入国际预警名单,年发文量约924篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 924 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 142 / 333

57.5

学科:ONCOLOGY SCIE Q2 151 / 333

54.8

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 151 / 322

53.3

学科:ONCOLOGY SCIE Q2 141 / 322

56.37

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.7 SJR:1.156 SNIP:0.997
学科类别 分区 排名 百分位
大类:Medicine 小类:Radiology, Nuclear Medicine and Imaging Q1 69 / 361

80%

大类:Medicine 小类:Oncology Q2 127 / 428

70%

大类:Medicine 小类:Cancer Research Q2 105 / 233

55%

期刊发文

  • The Clinical Relevance of Lymph Node Ratio for Post-Mastectomy Radiotherapy in Triple-Negative Breast Cancer: A Real-World Analysis With Propensity Score Matching Using SEER Databas

    Author: Zheng, Wei-Hong; Sun, Jia-Yuan; Kou, Jia; Li, Feng-Yan; Li, Guan-Qiao; Wu, San-Gang; He, Zhen-Yu

    Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71882

  • Identification of Prognostic Risk Factors in Older Patients With Extensive-Stage Small Cell Lung Cance

    Author: Liu, Jiayin; Liu, Xun; Li, Xiaolin; Liu, Ning; Wang, Bo; Feng, Li; Fan, Zhisong; Wang, Long; Han, Jing; Zhang, Xue; Jin, Hui; Li, Dan; Liu, Yan; Zuo, Jing; Wang, Yudong

    Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71885

  • Neoadjuvant Immunochemotherapy Increases the Abundance of Tertiary Lymphoid Structures and Lymphocyte Subpopulations Is Associated With Prognosis of Esophageal Squamous Cell Carcinom

    Author: Li, Ning; Zhang, Xiaoyan; Tang, Xupeng; Shen, Juanning; Qi, Qing; Wu, Huili; Zhao, Yuze; Wang, Shuo

    Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71889

  • Integration Analysis of Bayesian and Machine Learning for Heterogeneity, Biomarkers, and Optimal Combination Regimens of Pucotenlimab in Solid Tumor

    Author: He, Yingge; Gao, Changqing; Zhang, Shiyan; Hao, Yonghui; He, Shuning; Peng, Ke; Li, Liqi

    Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71893

  • Mecapegfilgrastim for Prophylaxis of Immunochemotherapy-Induced Neutropenia in Patients With Diffuse Large B-Cell Lymphoma: A Multicenter Pilot Tria

    Author: Wang, Jie; Li, He; Lin, Qiaochu; Guo, Yong; Ma, Hongbing; Xiang, Bing; Yang, Chenlu; Shen, Kai; Zhang, Chunlan; Yang, Kun; Ma, Chunrong; Zhai, Hong; Wei, Jin; Zuo, Yan; Zhou, Jie; Niu, Ting

    Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71821

  • Impact of Underlying Liver Disease on the Risk and Prognostic Factors of Breast Cancer Liver Metastases: A Retrospective Multicenter Cohort Stud

    Author: Wang, Xiaowen; Zhang, Yuan; Yang, Qiwei; Yang, Luo; Wang, Yanhui; Zeng, Xiangxin; Zou, Long; Guo, Yujuan; Zhou, Wenyang; Jiang, Yuqi; Wu, Jiezhong; Zhang, Peng; Zhou, Song; Zheng, Guangjuan; Huang, Tao; Wang, Genshu; Hu, Kunpeng

    Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71761

  • A Novel Nomogram Incorporating the Aggregate Index of Systemic Inflammation, Clinicopathological Parameters and Molecular Classification to Predict Recurrence of Endometrial Cancer: A Multi-Center Retrospective Stud

    Author: Tian, Chenfan; Zeng, Na; Tu, Yuan; Gong, Chunxia; Yu, Jiaxin; Rao, Kunying; Jiang, Peng

    Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71876

  • An XGBoost-Based Multicenter Model for Predicting HBV-Related Hepatocellular Carcinoma: Development and Validatio

    Author: Lin, Yong; Zhuo, Hai-Yan; Song, Hui-Wen; Zhou, Li-Na; Hong, Mei-Zhu; Lin, Chun; Guo, Peng-Fei; Pan, Jin-Shui

    Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71887